UConn spin-off gets stem cell patent for autoimmune diseases – Hartford Business
|
UConn spin-off gets stem cell patent for autoimmune diseases
Hartford Business ImStem Biotechnology Inc. and the University of Connecticut today announced that a joint patent was recently issued for human embryonic stem cell technology being used by ImStem to develop therapies for autoimmune diseases, with an initial focus on … |
